Background: Anemia is a major public health problem
affecting nearly a quarter of the world’s population. The global prevalence of
anemia was 39.8% in children aged 6 to 59 months and 29.9% in women of
childbearing age. Very commonly in the subtropics, helminthes or malaria
co-infects the same person, causing morbidities that vary according to age and
region. This research study aims to characterize the type of anemia observed in
<7 years old children in Western Côte d`Ivoire in order to recommend a
better strategy of care.
Methods: The study was carried out from March 2020 to May 2021 in 22 villages
of the “Tonkpi Region” (Man). It involved 451 children; boys and girls aged 3
months to 6 years who provided venous blood samples that were subjected to a
FBC for the diagnosis and characterization of anemia. The data were analysed by
using SPSS and STATA. Univariate analysis (Chi-2 test (x2) and P: (Probability)
were used for comparison between groups. Significant test was considered at a
threshold of 0.05.
Results: Among 451 selected children who completed the study, 221(49.0%) were
girls and 230(51.0 %) were boys. The prevalence of anemia was 248 (55.0%) of
which 76(30.7%) was mild, 164(66.1%) moderate and 8(3.2%) severe. Its
characterization showed the predominance of hypochromic microcytic anemia (HMA)
with 195(78.63%) followed by normochromic microcytic anemia 29(11.69%),
normochromic normocytic anemia 14(5.65%) and lastly, hypochromic normocytic
anemia 10(4.03%). The findings revealed that both genders are equally affected
though Children aged 3 months-2 years are slightly more affected compared to
older children (3 to 6 years).
Conclusion: The prevalence of anemia is high with moderate anemia and HMA being
more prevalent in children <7 years of which 30.7% mild, 66.1% moderate and
3.2% severe. Infants ≤2 years and the children ≤5 years were the most affected
at a prevalence of 66.0% and 51.5% respectively.
Author(s) Details:
Mocket Adolphe Ehouman,
Olopam Pharma and Research & Development, 10 BP 1274 Abidjan 10,
Côte d’Ivoire and Unité de Formation et de Recherche Biosciences, Université
Félix Houphouët-Boigny, 22 BP 770, Abidjan 22, Côte d’Ivoire.
Kouakou Eliezer
N`Goran,
Unité de
Formation et de Recherche Biosciences, Université Félix Houphouët-Boigny, 22 BP
770, Abidjan 22, Côte d’Ivoire.
Ahossan André Ehouman,
Institut de Cardiologie, Abidjan, BP V206 Abidjan, Côte d’Ivoire.
Pamela Nassinata Dosso,
Olopam Pharma and Research & Development, 10 BP 1274 Abidjan 10,
Côte d’Ivoire.
Please see the link here: https://stm.bookpi.org/RUDHR-V2/article/view/13501
No comments:
Post a Comment